Bill Detail
H.R. 3789
Congress: 119
Title
DTC Act of 2025
Summary
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025 This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage. The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Sponsor
Rep. David Taylor [R-OH-2]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Oct 2, 7:44 AM · synced 3h ago
Introduced
2025-06-05
Data source mode: cache
Bill Engagement
Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025 This bill requires consumer advertisements for prescription drugs and biological products to include cer…
Lobbyists on the case
- American Hospital Association1 filing · 28 lobs
- Lisa (Kidder) Hrobsky2025 Q2
- Gary Beck2026 Q1
Prepared intelligence brief
Connect the event to the surrounding activity.
Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.